<DOCUMENT>
<TYPE>EX-10.13
<SEQUENCE>12
<FILENAME>d918922dex1013.htm
<DESCRIPTION>EX-10.13
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.13</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 10.13 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Amendment No.&nbsp;2 to Collaboration and License Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Amendment No.&nbsp;2 to Collaboration and License Agreement (this &#147;<B><I>Amendment No.&nbsp;2</I></B>&#148;) is made and effective
as of August&nbsp;5, 2015, by and between <B>Proteostasis Therapeutics, Inc.</B>, a corporation existing under the laws of the State of Delaware, having a place of business at 200 Technology Square,
4<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor, Cambridge, MA 02139 (&#147;<B><I>PTI</I></B>&#148;) and <B>Astellas Pharma Inc.</B>, a Japanese corporation having its principal place of business at 5-1 Nihonbashi-Honcho 2-Chome,
Chuo-ku, Tokyo 103-8411, Japan (&#147;<B><I>Astellas</I></B>&#148;). Each of Astellas and PTI is sometimes referred to individually herein as a &#147;<B><I>Party</I></B>&#148; and collectively as the &#147;<B><I>Parties</I></B>&#148;<I>.</I> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Reference is hereby made to that certain Collaboration and License Agreement dated November&nbsp;4, 2014 and amended May&nbsp;1, 2015, by and
between the Parties (as amended, the &#147;<B><I>Agreement</I></B>&#148;). Capitalized terms used, but not defined herein shall have the meanings ascribed to such terms in the Agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">WHEREAS, the Parties now wish to further amend the Agreement pursuant to the terms and conditions set forth herein; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">NOW, THEREFORE, in consideration of the premises, the mutual covenants contained herein and other valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Parties hereby agree as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">1. Section&nbsp;2.2 is deleted in its entirety and
replaced with the following language: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman"><B>&#147;2.2 Project Selection; Research Term Extension</B>. During the first two (2)&nbsp;years
after the Effective Date, Astellas may specify up to two (2)&nbsp;Additional Projects to be conducted under the Collaboration (along with the Initial Project). If any such Additional Projects are specified by Astellas during the first two
(2)&nbsp;years after the Effective Date, the Research Term for the Agreement will be extended through the completion of the last Project. If either Party notifies the other Party that it desires to extend the Research Term for any Project beyond its
initial term, the other Party will reasonably consider such request and the Parties will discuss such extension.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">2. Except as
amended hereby, all other terms of the Agreement shall remain unchanged and in full force and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">3. This Amendment No.&nbsp;2 will
be governed by, and construed in accordance with, the laws of the state of New York, without taking into consideration any choice of law principles that would lead to the application of the laws of another jurisdiction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Signatures Appear on the Page Immediately Following </P> 
 
<p Style='page-break-before:always'>
<HR  SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
  
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">IN WITNESS WHEREOF, the Parties have caused this Amendment No.&nbsp;2 to be executed by their duly authorized
representatives. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> 
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">

 
<TR> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="42%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom"></TD> 
<TD WIDTH="4%"></TD> 
<TD VALIGN="bottom" WIDTH="1%"></TD> 
<TD WIDTH="42%"></TD></TR>

 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top" COLSPAN="3"><B>ASTELLAS PHARMA INC.</B></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top" COLSPAN="3"><B>PROTEOSTASIS THERAPEUTICS, INC.</B></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="16"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD> 
<TD HEIGHT="16" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">By:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Shunichiro Matsumoto</P></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">By:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Meenu Chhabra</P></TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Shunichiro Matsumoto</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Name:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Meenu Chhabra</TD></TR> 
<TR STYLE="font-size:1pt"> 
<TD HEIGHT="8"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD> 
<TD HEIGHT="8" COLSPAN="2"></TD></TR> 
<TR STYLE="font-family:Times New Roman; font-size:10pt"> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Vice President, Innovation Management</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top"></TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">Title:</TD> 
<TD VALIGN="bottom">&nbsp;</TD> 
<TD VALIGN="top">President and Chief Executive Officer</TD></TR>
</TABLE> 
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P> 
 
</BODY></HTML>
</TEXT>
</DOCUMENT>
